Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 3,127 shares at $51.38 ($160K) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Open-market sale of $160k RYTM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.38 | 1,209 | $62K | 38.9% |
| 2 | $51.38 | 1,209 | $62K | 38.9% |
| 3 | $49.82 | 709 | $35K | 22.1% |
| Total | $51.03 avg | 3,127 | $160K | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |